Antonio Nicolucci, MD [clinicaltrials_resource:9c109304cc5fd3ce07b66c57d7c8a17b]
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed [clinicaltrials:NCT00003053]Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice [clinicaltrials:NCT01192711]Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm. [clinicaltrials:NCT01745549]
overall official [clinicaltrials_vocabulary:overall-official]
Antonio Nicolucci, MD [clinicaltrials_resource:9c109304cc5fd3ce07b66c57d7c8a17b]
Bio2RDF identifier
9c109304cc5fd3ce07b66c57d7c8a17b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9c109304cc5fd3ce07b66c57d7c8a17b
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
nicolucci@negrisud.it
last name [clinicaltrials_vocabulary:last-name]
Antonio Nicolucci, MD
phone [clinicaltrials_vocabulary:phone]
+39 0872 570
phone ext [clinicaltrials_vocabulary:phone-ext]
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:9c109304cc5fd3ce07b66c57d7c8a17b
title
Antonio Nicolucci, MD
@en
type
label
Antonio Nicolucci, MD [clinicaltrials_resource:9c109304cc5fd3ce07b66c57d7c8a17b]
@en